$TECH·4

TECHNE CORP /MN/ · Aug 14, 4:20 PM ET

TECHNE CORP /MN/ 4

4 · TECHNE CORP /MN/ · Filed Aug 14, 2014

Insider Transaction Report

Form 4
Period: 2014-08-12
VERONNEAU MARCEL
VP-Hematology Operations
Transactions
  • Award

    Stock Option (Right to Buy)

    2014-08-12+15,00015,000 total
    Exercise: $94.35Exp: 2021-08-12Common Stock (15,000 underlying)
Holdings
  • Common Stock

    34,913
  • Common Stock

    (indirect: by Stock Bonus Plan)
    6,827
  • Stock Option (Right to Buy)

    Exercise: $79.41Exp: 2015-07-24Common Stock (385 underlying)
    385
  • Stock Option (Right to Buy)

    Exercise: $62.46Exp: 2016-07-23Common Stock (494 underlying)
    494
  • Stock Option (Right to Buy)

    Exercise: $66.25Exp: 2017-04-29Common Stock (10,000 underlying)
    10,000
  • Stock Option (Right to Buy)

    Exercise: $58.40Exp: 2017-07-29Common Stock (1,281 underlying)
    1,281
  • Stock Option (Right to Buy)

    Exercise: $76.15Exp: 2018-07-27Common Stock (20,000 underlying)
    20,000
  • Stock Option (Right to Buy)

    Exercise: $76.15Exp: 2018-08-27Common Stock (1,129 underlying)
    1,129
  • Stock Option (Right to Buy)

    Exercise: $74.05Exp: 2019-07-26Common Stock (1,097 underlying)
    1,097
  • Stock Option (Right to Buy)

    Exercise: $76.02Exp: 2020-07-31Common Stock (15,000 underlying)
    15,000
Footnotes (4)
  • [F1]Fully exercisable.
  • [F2]Vests 5,000 on each of 6/30/12, 6/30/13, 6/30/14, and 6/30/15.
  • [F3]Vests 3,750 on each of 8/1/14, 8/1/15, 8/1/16, and 8/1/17.
  • [F4]Vests 3,750 on each of 8/12/15, 8/12/16, 8/12/17, and 8/12/18.

Documents

1 file
  • 4
    edgar.xmlPrimary

    PRIMARY DOCUMENT